Adalimumab for Ocular Inflammation

Adalimumab therapy for refractory uveitis: results of a multicentre, open-label, prospective trial

(2013) Eric B Suhler et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

A three-centre experience with adalimumab for the treatment of non-infectious uveitis

(2012) Bianca Carola Dobner et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

Safety and Efficacy of Infliximab and Adalimumab for Refractory Uveitis in Juvenile Idiopathic Arthritis: 1-year Followup Data from the Italian Registry

(2012) M. E. ZANNIN et al.   JOURNAL OF RHEUMATOLOGY

Infliximab and Adalimumab for Uveitis

(2012) Joseph N. Martel et al.   OCULAR IMMUNOLOGY AND INFLAMMATION

Treatment of Refractory Uveitis with Adalimumab: A Prospective Multicenter Study of 131 Patients

(2012) Manuel Díaz-Llopis et al.   OPHTHALMOLOGY

Use of adalimumab in refractory non-infectious childhood chronic uveitis: efficacy in ocular disease--a case cohort interventional study

(2012) E. S. Sen et al.   RHEUMATOLOGY

Prevention of flare recurrences in childhood-refractory chronic uveitis: An open-label comparative study of adalimumab versus infliximab

(2010) Gabriele Simonini et al.   ARTHRITIS CARE & RESEARCH

Methotrexate for Ocular Inflammatory Diseases

(2009) Sapna Gangaputra et al.   OPHTHALMOLOGY

Adalimumab effectively reduces the rate of anterior uveitis flares in patients with active ankylosing spondylitis: results of a prospective open-label study

(2008) M Rudwaleit et al.   ANNALS OF THE RHEUMATIC DISEASES

Biologic agents in the management of inflammatory eye diseases

(2008) Kira Michalova et al.   CURRENT ALLERGY AND ASTHMA REPORTS

Adalimumab Therapy for Refractory Uveitis: A Pilot Study

(2008) Manuel Diaz-Llopis et al.   JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS

TNFα-blocking Agents or Conventional Immunosuppressive Drugs in the Therapy of Children with Uveitis? – An Evidence Based Approach

(2008) S. Winterhalter et al.   KLINISCHE PADIATRIE

Methods for Identifying Long-Term Adverse Effects of Treatment in Patients with Eye Diseases: The Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study

(2008) John H. Kempen et al.   OPHTHALMIC EPIDEMIOLOGY

Therapeutic monoclonal antibodies in ophthalmology

(2008) Eduardo B. Rodrigues et al.   PROGRESS IN RETINAL AND EYE RESEARCH

TNFα blockade in human diseases: Mechanisms and future directions

(2007) Maida Wong et al.   CLINICAL IMMUNOLOGY